Bayer says reintroducing Diane-35 in France
FRANKFURT (Reuters) - German drugmaker Bayer AG said on Wednesday it was cleared by the French health authority to reintroduce oral acne treatment Diane-35 to the French market after an eight-month suspension.
The European Commission said in July that Diane-35 was safe for use, a seal of approval which obliged France to allow sales of the product again.
France had suspended sales of Diane-35 after four deaths over the past 25 years were linked to its use.
The pill reduces acne by regulating hormones and blocking ovulation, and is often prescribed as a contraceptive even though it is not approved for this use.
- Obama condemns killing of reporter, U.S. hits militants in Iraq |
- Gaza war rages on, Hamas says Israel tried to kill its military chief |
- Four beheaded corpses found in Egypt's Sinai: security sources
- Father of Texas 'affluenza' teen arrested for impersonating police officer
- Islamic State opens new anti-U.S. front with beheading video
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video